LIKE THIS PART:
The three-year agreement takes effect from 1 April 2018 and will give Admedus direct access to promote the flagship ADAPT® tissue products, CardioCel® and VascuCel®, to more than 1500 hospitals who are members of the GPO’s purchasing network which has an estimated purchasing power of $US35B.
LIKE THIS PART: The three-year agreement takes effect from 1...
-
- There are more pages in this discussion • 63 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.71 |
Change
-0.290(1.61%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.71 | $16.28K | 902 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 473 | $17.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.06 | 18 | 3 |
View Market Depth
| Last trade - 11.55am 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |